Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Results from the TIMI-8 trial confirm unique risk/benefit profile of bivalirudin

Feb. 18, 2002

Novel factor Xa inhibitors for treatment of thromboembolic disorders

Feb. 15, 2002

Factor Xa inhibitors for thromboembolic disorders synthesized at DuPont

Feb. 14, 2002

Fibrolase derivative under joint development by Hyseq and Amgen as thrombolytic

Feb. 13, 2002

Spotlight on tPA and stroke at ISC

Feb. 13, 2002

Eptifibatide protects patients one year after coronary stent implantation

Feb. 12, 2002

Pyrazole derivatives prepared at DuPont for thromboembolic disorders

Feb. 12, 2002

Beneficial effects and safety demonstrated for gpIIb/IIIa antagonist in acute ischemic stroke

Feb. 12, 2002

Argatroban reduces stroke-associated mortality in HIT patients

Feb. 12, 2002

Arixtra introduced in the U.S. for preventing thromboembolic events following surgery

Feb. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...